DRX DLY S&P Biotech Bull 3XETF
13F holders, Q4 2025 (December 31)4holders −1
0new positions
1sold out
$159.97avg. 13F price*
At the end of Q4 2025, 4 institutions reported holding DRX DLY S&P Biotech Bull 3X in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holders were Parallel Advisors, LLC ($88K), Cornerstone Planning Group LLC ($6K) and Hollencrest Capital Management ($4K).
- Company
- DRX DLY S&P Biotech Bull 3X
- Filed as
- DIREXION DAILY S&P BIOTECH BULL 3X SHARES (Q4 2025)
- CUSIP
- 25490K323
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $5K |
All 13F filers, Q3 2025 → Q4 2025: 7 shares bought and 2,421 shares sold, net −2,414 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Parallel Advisors, LLC | 0.00% | Reduce -51.3% | 550 | $88K |
| Cornerstone Planning Group LLC | 0.00% | Reduce -98.0% | 36 | $6K |
| Hollencrest Capital Management | 0.00% | Add +43.8% | 23 | $4K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 10 | $2K |
"% of holder's portfolio" is DRX DLY S&P BIOTECH BULL 3X's weight in each manager's 13F, not the share of DRX DLY S&P Biotech Bull 3X the manager owns.